DNA (Cytosin-5)-Methyltransferase 3B

Caliebe A et al. (2014) A familial disorder of altered DNA-methylation.

Torroglosa A et al. (2014) Involvement of DNMT3B in the pathogenesis of Hirschsprung disease and its possible role as a regulator of neurogenesis in the human enteric nervous system.

Gendrel AV et al. (2012) Smchd1-dependent and -independent pathways determine developmental dynamics of CpG island methylation on the inactive X chromosome.

Gopalakrishnan S et al. (2009) DNMT3B interacts with constitutive centromere protein CENP-C to modulate DNA methylation and the histone code at centromeric regions.

None (2003) X inactivation-specific methylation of LINE-1 elements by DNMT3B: implications for the Lyon repeat hypothesis.

Shirohzu H et al. (2002) Three novel DNMT3B mutations in Japanese patients with ICF syndrome.

Beaulieu N et al. (2002) An essential role for DNA methyltransferase DNMT3B in cancer cell survival.

Hassan KM et al. (2001) Satellite 2 methylation patterns in normal and ICF syndrome cells and association of hypomethylation with advanced replication.

Hansen RS et al. (1999) The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome.

Carpenter NJ et al. (1988) Variable immunodeficiency with abnormal condensation of the heterochromatin of chromosomes 1, 9, and 16.

Jiang YL et al. (2005) DNMT3B mutations and DNA methylation defect define two types of ICF syndrome.

Bickmore WA et al. (2003) Perturbations of chromatin structure in human genetic disease: recent advances.

Ehrlich M et al. (2001) DNA methyltransferase 3B mutations linked to the ICF syndrome cause dysregulation of lymphogenesis genes.

Wijmenga C et al. (2000) Genetic variation in ICF syndrome: evidence for genetic heterogeneity.

Xu GL et al. (1999) Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene.

Wijmenga C et al. (1998) Localization of the ICF syndrome to chromosome 20 by homozygosity mapping.

Ooi SK et al. (2007) DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA.

Balada E et al. (2008) Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4+ T cells from patients with systemic lupus erythematosus.

Robertson KD et al. (1999) The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors.

Xie S et al. (1999) Cloning, expression and chromosome locations of the human DNMT3 gene family.

Rhee I et al. (2002) DNMT1 and DNMT3b cooperate to silence genes in human cancer cells.

Kim GD et al. (2002) Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases.

Paz MF et al. (2003) Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases.

Kawasaki H et al. (2004) Induction of DNA methylation and gene silencing by short interfering RNAs in human cells.

Viré E et al. (2006) The Polycomb group protein EZH2 directly controls DNA methylation.

Miller CA et al. (2007) Covalent modification of DNA regulates memory formation.

Okano M et al. (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development.

Okano M et al. (1998) Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases.

Yanagisawa Y et al. (2002) The human DNA methyltransferases DNMT3A and DNMT3B have two types of promoters with different CpG contents.

Kaneda M et al. (2004) Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting.

Fabbri M et al. (2007) MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B.

Orphanet article

NCBI article

OMIM.ORG article